Su et al. reported that endothelial cell (EC)-specific overexpression of IGFBP6 ameliorates atherosclerosis and endothelial cell inflammation by inhibiting the nuclear factor kappa B (NF-κB) pathway 35. This evidence concerns the gene IGFBP6 and atherosclerosis.